Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride

被引:103
作者
Mandal, Sonjoy [1 ]
Thimmasetty, Manjunath K. M. J. [1 ]
Prabhushankar, G. L. [1 ]
Geetha, M. S. [1 ]
机构
[1] Bapuji Pharm Coll, Dept Ind Pharm, Davangere 577004, Karnataka, India
关键词
Gelling capacity; in situ gel; in vitro diffusion study; moxifloxacin hydrochloride; rheological evaluation;
D O I
10.4103/2230-973X.100042
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background/Aim: The aim of the present investigation is to prepare and evaluate in situ gel-forming ophthalmic drug delivery system of moxifloxacin hydrochloride. Materials and Methods: Sodium alginate, a novel ophthalmic gel-forming mucoadhesive polymer, which gets converted to gel in the presence of divalent-cations (calcium ion) present in the lachrymal fluid, was used as the gelling agent. Hydroxy propyl methyl cellulose (HPMC) is a mucoadhesive polymer used as viscosity enhancer. Suitable concentrations of buffering agents were used to adjust the pH to 6.5. All the formulations were sterilized in an autoclave at 121 degrees C for 15 minutes. The formulations were evaluated for clarity, pH measurement, gelling capacity, drug content estimation, rheological study, in vitro diffusion study, antibacterial activity, isotonicity, and eye irritation study. Results: The developed formulations exhibited sustained release of drug from formulation over a period of 10 hours thus increasing residence time of the drug. The optimized formulations were tested for eye irritation on albino rabbit (male). The formulations were found to be non-irritating with no ocular damage or abnormal clinical signs to the cornea, iris or conjunctiva observed. Conclusion: These in situ gelling systems containing gums may be a valuable alternative to the conventional systems.
引用
收藏
页码:78 / 82
页数:5
相关论文
共 13 条
[1]  
Ashim KM, 1993, OPHTHALMIC DRUG DELI, V58, P105
[2]   Rheological evaluation of Gelrite® in situ gels for ophthalmic use [J].
Carlfors, J ;
Edsman, K ;
Petersson, R ;
Jornving, K .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 6 (02) :113-119
[3]  
Draize JH, 1944, J PHARMACOL EXP THER, V82, P377
[4]   Rheological evaluation of poloxamer as an in situ gel for ophthalmic use [J].
Edsman, K ;
Carlfors, J ;
Petersson, R .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 6 (02) :105-112
[5]   Formulation and evaluation of ophthalmic preparations of acetazolamide [J].
Kaur, IP ;
Singh, M ;
Kanwar, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 199 (02) :119-127
[6]   Vesicular systems in ocular drug delivery: an overview [J].
Kaur, IP ;
Garg, A ;
Singla, AK ;
Aggarwal, D .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 269 (01) :1-14
[7]   Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin [J].
Liu, Zhidong ;
Li, Jiawei ;
Nie, Shufang ;
Liu, Hui ;
Ding, Pingtian ;
Pan, Weisan .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 315 (1-2) :12-17
[8]   Regulatory aspects of stability testing in Europe [J].
Matthews, BR .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (07) :831-856
[9]  
Mitan R, 2007, DRUG DELIV TECHNOL, V5, P44
[10]  
Pandit J. K., 2007, Indian Journal of Pharmaceutical Sciences, V69, P37